ES511604A0 - "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". - Google Patents

"un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".

Info

Publication number
ES511604A0
ES511604A0 ES511604A ES511604A ES511604A0 ES 511604 A0 ES511604 A0 ES 511604A0 ES 511604 A ES511604 A ES 511604A ES 511604 A ES511604 A ES 511604A ES 511604 A0 ES511604 A0 ES 511604A0
Authority
ES
Spain
Prior art keywords
angioquinase
vasal
callable
vascular
chemically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES511604A
Other languages
English (en)
Other versions
ES8501797A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Manetti & Roberts Italo Brit
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of ES8501797A1 publication Critical patent/ES8501797A1/es
Publication of ES511604A0 publication Critical patent/ES511604A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ES511604A 1981-04-23 1982-04-22 "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"". Granted ES511604A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (2)

Publication Number Publication Date
ES8501797A1 ES8501797A1 (es) 1984-12-01
ES511604A0 true ES511604A0 (es) 1984-12-01

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
ES511604A Granted ES511604A0 (es) 1981-04-23 1982-04-22 "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".

Country Status (16)

Country Link
US (2) US4471053A (es)
EP (1) EP0064036B1 (es)
JP (1) JPS57181019A (es)
AT (1) ATE15071T1 (es)
AU (1) AU548758B2 (es)
CA (1) CA1184138A (es)
DE (1) DE3265559D1 (es)
DK (1) DK180682A (es)
ES (1) ES511604A0 (es)
IE (1) IE53107B1 (es)
IL (1) IL65448A (es)
IT (1) IT1170913B (es)
NO (1) NO821287L (es)
NZ (1) NZ200254A (es)
PT (1) PT74743B (es)
ZA (1) ZA822703B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
EP1890820A4 (en) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc SYSTEMS AND METHOD FOR PRODUCING MEMBRANES
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
DK180682A (da) 1982-10-24
ES8501797A1 (es) 1984-12-01
JPS57181019A (en) 1982-11-08
US4471053A (en) 1984-09-11
ATE15071T1 (de) 1985-09-15
AU8237582A (en) 1982-10-28
EP0064036A1 (en) 1982-11-03
IT8148332A1 (it) 1982-10-23
IE820952L (en) 1982-10-23
PT74743A (en) 1982-05-01
PT74743B (en) 1983-11-09
IL65448A0 (en) 1982-07-30
EP0064036B1 (en) 1985-08-21
AU548758B2 (en) 1986-01-02
NZ200254A (en) 1985-07-12
IT8148332A0 (it) 1981-04-23
IE53107B1 (en) 1988-06-22
IL65448A (en) 1985-07-31
CA1184138A (en) 1985-03-19
ZA822703B (en) 1983-03-30
IT1170913B (it) 1987-06-03
NO821287L (no) 1982-10-25
US4532129A (en) 1985-07-30
DE3265559D1 (en) 1985-09-26

Similar Documents

Publication Publication Date Title
ES511604A0 (es) "un procedimiento para la obtencion de un principio activo fibrinolitico vasal o vascular, quimicamente denominable "enzima angioquinasa"".
Ohsaka Hemorrhagic, necrotizing and edema-forming effects of snake venoms
ES2035847T3 (es) Un procedimiento para la elaboracion de una preparacion farmaceutica.
ES2035259T5 (es) Procedimiento para la fabricacion de un articulo absorbente.
ATE121628T1 (de) Pharmazeutische zubereitung auf basis von lys- plasminogen.
ES8402942A1 (es) Procedimiento para la produccion de un preparado de tromboplastina de tejidos.
SE8602405D0 (sv) Ny formulering
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NO171417C (no) Middel for paavisning og bestemmelse av peroksydase-aktivitet, en fremgangsmaate for fremstilling av midlet samt detsanvendelse
NO914217L (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
ES2000871A6 (es) Un procedimiento para producir un copolimero de bloques selectivamente hidrogenado y fuoncionalizado
ATE210455T1 (de) Vwf propeptide enthaltendes pharmazeutisches präparat
AU5121579A (en) Isolation of tissue protein ppg.
MX169931B (es) Procedimiento para determinar la catividad de serinproteasas inhibidores de serinproteasas
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
EP0044343A4 (en) PROTHROMBIN-CONTAINING THERAPEUTIC COMPOSITIONS AND METHOD FOR THE PRODUCTION OF ENZYMATICALLY ACTIVE BLOOD-COUTTERING FACTORS FROM PROTHROMBIN-CONTAINING BLOOD FRACTIONS.
ES2056149T3 (es) Ambliommina, una nueva sustancia activa para la terapia anticoagulante.
PE43995A1 (es) Procedimiento para la prevencion de la degradacion de la proteina c
ES2058931T3 (es) Un reactivo para la deteccion de actividad fibrinolitica.
DE3883044D1 (de) Wirkstoff zur tumorbekaempfung.
ES469908A1 (es) Procedimiento de utilizacion de salinomicina.
SE8600987D0 (sv) Forfarande for framstellning av ett protein- koncentrat ur helblod
JPS54143588A (en) Preparation of sterilized, immobilized enzyme
DE3678820D1 (de) Verwendung einer loesung von alpha-chymotrypsin.
SU1197669A1 (ru) Способ лечени нагноительных заболеваний легких

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519